Treatment Duration of Cholinesterase Inhibitor Formulations in Alzheimer's Disease
- DOI
- 10.1016/j.jamda.2026.106481
- Published
- 2026-11
- Container
- Journal of the American Medical Directors Association
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jamda.2026.106481,
title = {Treatment Duration of Cholinesterase Inhibitor Formulations in Alzheimer's Disease},
author = {So Sato and Yusuke Sasabuchi and Hayato Yamana and Takahide Kohro and Hideo Yasunaga},
year = {2026},
journal = {Journal of the American Medical Directors Association},
doi = {10.1016/j.jamda.2026.106481},
url = {https://doi.org/10.1016/j.jamda.2026.106481}
}RIS
TY - JOUR TI - Treatment Duration of Cholinesterase Inhibitor Formulations in Alzheimer's Disease AU - So Sato AU - Yusuke Sasabuchi AU - Hayato Yamana AU - Takahide Kohro AU - Hideo Yasunaga PY - 2026 JO - Journal of the American Medical Directors Association DO - 10.1016/j.jamda.2026.106481 UR - https://doi.org/10.1016/j.jamda.2026.106481 ER -
APA
Sato, S., Sasabuchi, Y., Yamana, H., Kohro, T., & Yasunaga, H. (2026). Treatment Duration of Cholinesterase Inhibitor Formulations in Alzheimer's Disease. Journal of the American Medical Directors Association. https://doi.org/10.1016/j.jamda.2026.106481
Source records
- crossref · retrieved 2026-09-25T03:44:34.468Z